Potential clinical benefits and cost savings of universal leucocyte- depletion of blood components

Transfusion Science

Volumn 19, Issue 4, 1998, Pages 343-346

  Murphy, M F ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENICITY; ARTICLE; BLOOD TRANSFUSION REACTION; COST CONTROL; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; LEUKAPHERESIS; PRACTICE GUIDELINE; UNITED KINGDOM;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CELL SEPARATION; COST-BENEFIT ANALYSIS; CREUTZFELDT-JAKOB SYNDROME; GOVERNMENT AGENCIES; GREAT BRITAIN; GUIDELINES; HEMATOLOGIC DISEASES; HUMANS; INTRAOPERATIVE CARE; LENGTH OF STAY; LEUKOCYTES; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SAFETY; SURGICAL PROCEDURES, OPERATIVE;

EID: 0346967301     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(98)00060-5     Document Type: Article

References (8)

1. British Committee for Standards in Haematology: Guidelines on the clinical use of leucocyte-depleted blood components. Transfusion Medicine 1998; 8:59-71.
2. The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New England Journal of Medicine 1997; 337:1861-1869.
3. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W: A comparison of filtered leukocyte-reduced and cytomegalovirus negative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86:3598-3603.
4. Oksanen K, Elonen E: Impact of leucocyte-depleted blood components on the haematological recovery and prognosis of patients with acute myeloid leukaemia. British Journal of Haematology 1993; 84: 639-647.
5. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Moller-Nielsen C, Hanberg-Sorensen F, Hokland M: Postoperative infection and natural killer function following blood transfusion in patients undergoing elective colorectal surgery. British Journal of Surgery 1992; 79:513-516.
6. Jensen LS, Grunnet N, Hanberg-Sorensen F, Jorgensen J: Cost-effectiveness of blood transfusion and white cell reduction in patients undergoing elective colorectal surgery. Transfusion 1995; 35:719-722.
7. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N: Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion after colorectal surgery. Lancet 1996; 348:841-845.
8. Blajchman MA: Allogeneic blood transfusions, immunomodulation, and post-operative bacterial infection: Do we have the answers yet? Transfusion 1997; 37:121-125.